Thermo Fisher Scientific Gross Profit 2010-2024 | TMO
Thermo Fisher Scientific annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Thermo Fisher Scientific gross profit for the quarter ending September 30, 2024 was $4.328B, a 0.28% increase year-over-year.
- Thermo Fisher Scientific gross profit for the twelve months ending September 30, 2024 was $17.273B, a 0.23% decline year-over-year.
- Thermo Fisher Scientific annual gross profit for 2023 was $17.1B, a 9.86% decline from 2022.
- Thermo Fisher Scientific annual gross profit for 2022 was $18.971B, a 3.4% decline from 2021.
- Thermo Fisher Scientific annual gross profit for 2021 was $19.638B, a 22.71% increase from 2020.
| Thermo Fisher Scientific Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $17,100 |
| 2022 | $18,971 |
| 2021 | $19,638 |
| 2020 | $16,004 |
| 2019 | $11,328 |
| 2018 | $10,857 |
| 2017 | $9,448 |
| 2016 | $8,372 |
| 2015 | $7,756 |
| 2014 | $7,492 |
| 2013 | $5,529 |
| 2012 | $5,296 |
| 2011 | $4,794 |
| 2010 | $4,262 |
| 2009 | $3,898 |
| Thermo Fisher Scientific Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $4,328 |
| 2024-06-30 | $4,347 |
| 2024-03-31 | $4,205 |
| 2023-12-31 | $4,393 |
| 2023-09-30 | $4,316 |
| 2023-06-30 | $4,251 |
| 2023-03-31 | $4,140 |
| 2022-12-31 | $4,606 |
| 2022-09-30 | $4,302 |
| 2022-06-30 | $4,599 |
| 2022-03-31 | $5,464 |
| 2021-12-31 | $5,254 |
| 2021-09-30 | $4,651 |
| 2021-06-30 | $4,524 |
| 2021-03-31 | $5,209 |
| 2020-12-31 | $5,556 |
| 2020-09-30 | $4,331 |
| 2020-06-30 | $3,377 |
| 2020-03-31 | $2,740 |
| 2019-12-31 | $3,035 |
| 2019-09-30 | $2,763 |
| 2019-06-30 | $2,823 |
| 2019-03-31 | $2,707 |
| 2018-12-31 | $2,924 |
| 2018-09-30 | $2,615 |
| 2018-06-30 | $2,738 |
| 2018-03-31 | $2,580 |
| 2017-12-31 | $2,671 |
| 2017-09-30 | $2,300 |
| 2017-06-30 | $2,284 |
| 2017-03-31 | $2,193 |
| 2016-12-31 | $2,282 |
| 2016-09-30 | $2,054 |
| 2016-06-30 | $2,079 |
| 2016-03-31 | $1,958 |
| 2015-12-31 | $2,108 |
| 2015-09-30 | $1,883 |
| 2015-06-30 | $1,942 |
| 2015-03-31 | $1,823 |
| 2014-12-31 | $2,092 |
| 2014-09-30 | $1,934 |
| 2014-06-30 | $1,847 |
| 2014-03-31 | $1,620 |
| 2013-12-31 | $1,482 |
| 2013-09-30 | $1,348 |
| 2013-06-30 | $1,363 |
| 2013-03-31 | $1,336 |
| 2012-12-31 | $1,386 |
| 2012-09-30 | $1,298 |
| 2012-06-30 | $1,321 |
| 2012-03-31 | $1,290 |
| 2011-12-31 | $1,294 |
| 2011-09-30 | $1,219 |
| 2011-06-30 | $1,161 |
| 2011-03-31 | $1,120 |
| 2010-12-31 | $1,085 |
| 2010-09-30 | $1,062 |
| 2010-06-30 | $1,049 |
| 2010-03-31 | $1,066 |
| 2009-12-31 | $1,011 |
| 2009-09-30 | $1,011 |
| 2009-06-30 | $988 |
| 2009-03-31 | $887 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $204.393B | $42.857B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $193.619B | 101.23 |
| Edwards Lifesciences (EW) | United States | $43.533B | 27.64 |
| Alcon (ALC) | Switzerland | $42.700B | 28.57 |
| IQVIA Holdings (IQV) | United States | $36.494B | 20.11 |
| IDEXX Laboratories (IDXX) | United States | $35.790B | 42.15 |
| DexCom (DXCM) | United States | $31.431B | 47.33 |
| Waters (WAT) | United States | $22.876B | 33.83 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.760B | 0.00 |
| Hologic (HOLX) | United States | $17.141B | 18.51 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.008B | 14.38 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.294B | 28.60 |
| Penumbra (PEN) | United States | $9.735B | 95.36 |
| Masimo (MASI) | United States | $9.336B | 45.18 |
| Teleflex (TFX) | United States | $8.528B | 13.60 |
| Glaukos (GKOS) | United States | $7.879B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.728B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.717B | 26.73 |
| Inari Medical (NARI) | United States | $3.408B | 0.00 |
| Veracyte (VCYT) | United States | $3.372B | 101.19 |
| LivaNova (LIVN) | United Kingdom | $2.796B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.337B | 17.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.267B | 0.00 |
| TransMedics (TMDX) | United States | $2.261B | 71.66 |
| Elekta AB (EKTAY) | Sweden | $2.229B | 20.04 |
| Integra LifeSciences Holdings (IART) | United States | $1.864B | 9.74 |
| RxSight (RXST) | United States | $1.515B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.254B | 83.11 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.062B | 0.00 |
| Paragon 28 (FNA) | United States | $0.874B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.708B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 16.49 |
| IRadimed (IRMD) | United States | $0.699B | 37.80 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.558B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 31.48 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.453B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.440B | 23.83 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.331B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.230B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.162B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.12 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.011B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |